Literature DB >> 19888967

Trafficking and signalling of gonadotrophin-releasing hormone receptors: an automated imaging approach.

A R Finch1, K R Sedgley, S P Armstrong, C J Caunt, C A McArdle.   

Abstract

Gonadotrophin-releasing hormone (GnRH) is a neuropeptide that mediates central control of reproduction by stimulating gonadotrophin secretion from the pituitary. It acts via 7 transmembrane region (7TM) receptors that lack C-terminal tails, regions that for many 7TM receptors, are necessary for agonist-induced phosphorylation and arrestin binding as well as arrestin-dependent desensitization, internalization and signalling. Recent work has revealed that human GnRH receptors (GnRHR) are poorly expressed at the cell surface. This apparently reflects inefficient exit from the endoplasmic reticulum, which is thought to be increased by pharmacological chaperones (non-peptide GnRHR antagonists that increase cell surface GnRHR expression) or reduced by point mutations that further impair GnRHR trafficking and thereby cause infertility. Here, we review recent work in this field, with emphasis on the use of semi-automated imaging to interrogate compartmentalization and trafficking of these unique 7TM receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888967      PMCID: PMC2829201          DOI: 10.1111/j.1476-5381.2009.00413.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

1.  Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization.

Authors:  M Blomenröhr; A Heding; R Sellar; R Leurs; J Bogerd; K A Eidne; G B Willars
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

2.  Conformational disease.

Authors:  R R Kopito; D Ron
Journal:  Nat Cell Biol       Date:  2000-11       Impact factor: 28.824

Review 3.  Localization of G-protein-coupled receptors in health and disease.

Authors:  S W Edwards; C M Tan; L E Limbird
Journal:  Trends Pharmacol Sci       Date:  2000-08       Impact factor: 14.819

4.  Desensitization and internalization of human and xenopus gonadotropin-releasing hormone receptors expressed in alphaT4 pituitary cells using recombinant adenovirus.

Authors:  J N Hislop; M T Madziva; H M Everest; T Harding; J B Uney; G B Willars; R P Millar; B E Troskie; J S Davidson; C A McArdle
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

Review 5.  Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.

Authors:  A V Schally
Journal:  Peptides       Date:  1999       Impact factor: 3.750

6.  Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor.

Authors:  U E Petaja-Repo; M Hogue; A Laperriere; P Walker; M Bouvier
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

7.  Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.

Authors:  Ségolène Galandrin; Michel Bouvier
Journal:  Mol Pharmacol       Date:  2006-08-10       Impact factor: 4.436

8.  Rapid down-regulation of the type I inositol 1,4,5-trisphosphate receptor and desensitization of gonadotropin-releasing hormone-mediated Ca2+ responses in alpha T3-1 gonadotropes.

Authors:  G B Willars; J E Royall; S R Nahorski; F El-Gehani; H Everest; C A McArdle
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

Review 9.  Will GnRH antagonists improve prostate cancer treatment?

Authors:  Ilpo Huhtaniemi; Richard White; Craig A McArdle; Bo-Eric Persson
Journal:  Trends Endocrinol Metab       Date:  2008-11-13       Impact factor: 12.015

10.  Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors.

Authors:  Ann R Finch; Christopher J Caunt; Stephen P Armstrong; Craig A McArdle
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-08       Impact factor: 4.249

View more
  8 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Themed section: Imaging in pharmacology.

Authors:  Anthony P Davenport; Craig Daly
Journal:  Br J Pharmacol       Date:  2010-02       Impact factor: 8.739

3.  Imaging--the interface with pharmacology: looking to the future.

Authors:  Andrew J Lawrence; Andreas Heinz
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 5.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

Review 6.  Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system.

Authors:  Lee E Eiden; Vito S Hernández; Sunny Z Jiang; Limei Zhang
Journal:  Cell Mol Life Sci       Date:  2022-08-23       Impact factor: 9.207

7.  Dynamic evolution of the GnRH receptor gene family in vertebrates.

Authors:  Barry L Williams; Yasuhisa Akazome; Yoshitaka Oka; Heather L Eisthen
Journal:  BMC Evol Biol       Date:  2014-10-25       Impact factor: 3.260

8.  Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Authors:  József Murányi; Attila Varga; Pál Gyulavári; Kinga Pénzes; Csilla E Németh; Miklós Csala; Lilla Pethő; Antal Csámpai; Gábor Halmos; István Peták; István Vályi-Nagy
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.